NCT02913391

Brief Summary

Cardiac surgery can evolve with complications in the postoperative period, atelectasis and hypoxemia are the major pulmonary dysfunctions. They can lead to a prolonged length of stay in the hospital, increasing morbidity and mortality. In order to prevent or reduce such complications noninvasive ventilation (NIV) has been used in the postoperative period in a prophylactic and therapeutic way. The use of positive end-expiratory pressure (PEEP) is widely practice in intensive care unit (ICU), being used in patients under mechanical ventilation, NIV and exercises with intermittent positive pressure. The recruitment maneuver (RM) consists of sustained increase of pressure in the airway using PEEP in individuals with hypoxemia, in order to minimize the deleterious effects from alveolar collapse, providing a more homogeneous ventilation of the pulmonary parenchyma increasing the pulmonary area available for gas exchange and, consequently, arterial oxygenation. In recent years the increase in the application of PEEP in cardiac patients under has shown great benefits and the use of NIV to improve oxygenation by the reversal of atelectasis is already used and recommended in hospital routine. Despite NIV being used in great proportion, the relevant literature is poor in showing studies with NIV associated with RM in postoperative period of cardiac surgery. Therefore, the aims of this study are to evaluate if the use of NIV associated with RM improves oxygenation and if it can be safely applied in coronary artery bypass grafting (CABG) with cardiopulmonary bypass (CPB) postoperative patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
34

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2016

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

September 14, 2016

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 23, 2016

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2017

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2017

Completed
Last Updated

January 12, 2018

Status Verified

January 1, 2018

Enrollment Period

1 year

First QC Date

September 14, 2016

Last Update Submit

January 10, 2018

Conditions

Keywords

noninvasive ventilationmyocardial revascularizationpulmonary atelectasishypoxiapositive end-expiratory pressurecoronary artery bypass graftingextracorporeal circulation

Outcome Measures

Primary Outcomes (1)

  • Oxygenation improvement

    Arterial blood gas sample was collected in pressure support ventilation on the day of extubation and on the following days, it was collected after 2 minutes in room air, daily until ICU discharge. Oxygenation improvement was the difference between partial oxygen pressure at the day of ICU discharge and the day of extubation.

    from date of extubation until the date of ICU discharge, approximately one month

Secondary Outcomes (7)

  • Atelectasis score improvement

    from date of extubation until the date of ICU discharge, approximately one month

  • Barotrauma

    from date of extubation until the date of ICU discharge, approximately one month

  • Arrhythmia

    from date of extubation until the date of ICU discharge, approximately one month

  • Hemodynamic instability

    from date of extubation until the date of ICU discharge, approximately one month

  • Extubation failure rate

    from date of extubation until the date of ICU discharge, approximately one month

  • +2 more secondary outcomes

Study Arms (2)

recruitment group (RG)

EXPERIMENTAL

After extubation the patient who was randomized to the Recruitment Group (RG) used noninvasive ventilation (NIV) associated with recruitment maneuver with PEEP 15 cm H2O and afterwards 20 cm H2O remaining 2 minutes in each, then being maintained in NIV until 30 minutes with pressure support for a tidal volume of 6 mL/Kg, PEEP 8 cm H2O, Fraction of inspired oxygen (FiO2) for a peripheral oxygen saturation (SpO2) ≥ 95%.

Other: recruitment group (RG)

control group (CG)

ACTIVE COMPARATOR

After extubation the patient who was randomized to the Control Group (CG) used noninvasive ventilation (NIV) for 30 minutes with pressure support for a tidal volume of 6 ml/Kg, PEEP 8 cm H2O, FiO2 for a SpO2 ≥ 95%.

Other: control group (CG)

Interventions

After extubation the patient who was randomized to the Recruitment Group will use noninvasive ventilation (NIV) with alveolar recruitment maneuver with PEEP 15 cm H2O and afterwards 20 cm H2O remaining 2 minutes in each, then being maintained in NIV for 30 minutes with pressure support for a tidal volume of 6 ml/Kg, PEEP 8 cm H2O, Fraction of inspired oxygen for a peripheral arterial Saturation of Oxygen ≥ 95%.

recruitment group (RG)

After extubation the patient who was randomized to the Control Group will use noninvasive ventilation (NIV) for 30 minutes with pressure support for a tidal volume of 6ml/Kg, PEEP 8 cm H2O, Fraction of inspired oxygen for a peripheral arterial Saturation of Oxygen ≥ 95%.

control group (CG)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged 18 years or over;
  • Hypoxemia defined by ratio PaO2/FiO2 \< 300 in extubation;
  • Glasgow Coma Scale \> 11 after extubation;
  • Chest radiograph with radiological atelectasis score ≥ 2 The radiological score of atelectasis: 0, without atelectasis; 1, line of atelectasis or discrete infiltration; 2, partial atelectasis; 3, lobar atelectasis and 4, bilateral lobar atelectasis.

You may not qualify if:

  • Use of vasoconstrictor drugs in increasing doses throughout the last two hours (norepinephrine increasing ≥ 0.5 mcg / kg / min, or increase of dopamine ≥ 5mcg/kg/min) or arterial pressure \<65 mmHg;
  • Presence of a tracheostomy;
  • Global initiative for Obstructive Lung Disease (GOLD) classification \> 2 and pulmonary fibrosis;
  • Contraindication to use of NIV;
  • Refuse of RM by the surgeon / doctor in charge.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital do Coracao

São Paulo, Brazil

Location

MeSH Terms

Conditions

HypoxiaPulmonary Atelectasis

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Signs and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsLung DiseasesRespiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Carolina Fu, PhD

    University of Sao Paulo

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Post graduating, Department of Physiotherapy, Communication Science & Disorders, Occupational Therapy - Medical School of University of São Paulo

Study Record Dates

First Submitted

September 14, 2016

First Posted

September 23, 2016

Study Start

April 1, 2016

Primary Completion

April 1, 2017

Study Completion

September 1, 2017

Last Updated

January 12, 2018

Record last verified: 2018-01

Locations